Search Results - "Torres Torres, Keila E"

Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer by Banda, Malathi, Speyer, Cecilia L, Semma, Sara N, Osuala, Kingsley O, Kounalakis, Nicole, Torres Torres, Keila E, Barnard, Nicola J, Kim, Hyunjin J, Sloane, Bonnie F, Miller, Fred R, Goydos, James S, Gorski, David H

“…TNBC is an aggressive breast cancer subtype that does not express hormone receptors (estrogen and progesterone receptors, ER and PR) or amplified human…”
Get full text

Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells by SATELLI, Arun, MITRA, Abhisek, LUDWIG, Joseph A, KLEINERMAN, Eugenie S, SHULIN LI, CUTRERA, Jeffry J, DEVARIE, Marcos, XUEQING XIA, INGRAM, Davis R, DIBRA, Denada, SOMAIAH, Neeta, TORRES, Keila E, RAVI, Vinod

“…To date, no specific marker exists for the detection of circulating tumor cells (CTC) from different types of sarcomas, though tools are available for…”
Get full text

Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma by Keung, Emily Z., Chiang, Yi-Ju, Voss, Rachel K., Cormier, Janice N., Torres, Keila E., Hunt, Kelly K., Feig, Barry W., Roland, Christina L.

“…The incidence and clinical significance of lymph node metastasis (LNM, N1) in soft tissue sarcoma (STS) is unclear. Recent studies have focused on…”
Get full text

Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors by Watson, Kelsey L, Al Sannaa, Ghadah A, Kivlin, Christine M, Ingram, Davis R, Landers, Sharon M, Roland, Christina L, Cormier, Janice N, Hunt, Kelly K, Feig, Barry W, Ashleigh Guadagnolo, B, Bishop, Andrew J, Wang, Wei-Lien, Slopis, John M, McCutcheon, Ian E, Lazar, Alexandar J, Torres, Keila E

“…OBJECTIVE Malignant peripheral nerve sheath tumors (MPNSTs) are an aggressive group of soft tissue sarcomas that can arise sporadically, in the context of…”
Get full text

Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma by Keung, Emily Z, Lazar, Alexander J, Torres, Keila E, Wang, Wei-Lien, Cormier, Janice N, Ashleigh Guadagnolo, B, Bishop, Andrew J, Lin, Heather, Hunt, Kelly K, Bird, Justin, Lewis, Valerae O, Patel, Shreyaskumar R, Wargo, Jennifer A, Somaiah, Neeta, Roland, Christina L

“…Soft tissue sarcomas are a heterogeneous and rare group of solid tumors of mesenchymal origin that can arise anywhere in the body. Although surgical resection…”
Get full text

Myxofibrosarcoma by Roland, Christina L., MD, Wang, Wei-Lien, MD, Lazar, Alexander J., MD, PhD, Torres, Keila E., MD, PhD

“…Myxofibrosarcoma is a unique subtype of soft tissue sarcoma with a locally infiltrative behavior. High-quality MRI imaging is critical for preoperative…”
Get full text

Detection of circulating tumor cells from cryopreserved human sarcoma peripheral blood mononuclear cells by Li, Heming, Meng, Qing H., Noh, Hyangsoon, Batth, Izhar Singh, Somaiah, Neeta, Torres, Keila E., Xia, Xueqing, Wang, Ruoyu, Li, Shulin

“…Circulating tumor cells (CTCs) enter the vasculature or lymphatic system after shedding from the primary tumor. CTCs may serve as “seed” cells for tumor…”
Get full text

Rare osteosarcoma cell subpopulation protein array and profiling using imaging mass cytometry and bioinformatics analysis by Batth, Izhar S, Meng, Qing, Wang, Qi, Torres, Keila E, Burks, Jared, Wang, Jing, Gorlick, Richard, Li, Shulin

“…Single rare cell characterization represents a new scientific front in personalized therapy. Imaging mass cytometry (IMC) may be able to address all these…”
Get full text

Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership by Witt, Russell G., Voss, Rachel K., Chiang, Yi-Ju, Nguyen, Sa, Scally, Christopher P., Lin, Patrick P., Torres, Keila E., Moon, Bryan S., Satcher, Robert L., Hunt, Kelly K., Bird, Justin E., Feig, Barry W., Lewis, Valerae O., Roland, Christina L., Keung, Emily Z.

“…Background Regional lymph node metastasis in extremity and trunk soft tissue sarcoma (ETSTS) is rare with no standardized management. We sought to determine…”
Get full text

ASO Visual Abstract: Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma (ETSTS): A Survey of the Society of Surgical Oncology (SSO) and Musculoskeletal Tumor Society (MSTS) Membership by Witt, Russell G., Voss, Rachel K., Chiang, Yi-Ju, Nguyen, Sa, Scally, Christopher P., Lin, Patrick P., Torres, Keila E., Moon, Bryan S., Satcher, Robert L., Hunt, Kelly K., Bird, Justin E., Feig, Barry W., Lewis, Valerae O., Roland, Christina L., Keung, Emily Z.

Get full text

Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy by Keung, Emily Z., Tsai, Jen-Wei, Ali, Ali M., Cormier, Janice N., Bishop, Andrew J., Guadagnolo, B. Ashleigh, Torres, Keila E., Somaiah, Neeta, Hunt, Kelly K., Wargo, Jennifer A., Lazar, Alexander J., Wang, Wei-Lien, Roland, Christina L.

“…Background: Undifferentiated pleomorphic sarcoma of the extremity and trunk (ET-UPS) presents a unique therapeutic challenge. Although immunotherapy has…”
Get full text

Recurrence patterns of retroperitoneal leiomyosarcoma and impact of salvage surgery by Ikoma, Naruhiko, Torres, Keila E., Lin, Heather Y., Ravi, Vinod, Roland, Christina L., Mann, Gary N., Hunt, Kelly K., Cormier, Janice N., Feig, Barry W.

“…Background Optimal treatment strategies for retroperitoneal leiomyosarcoma (RPLMS), particularly recurrent disease, are unknown. Methods We searched the tumor…”
Get full text

Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma by Roland, Christina L, Boland, Genevieve M, Demicco, Elizabeth G, Lusby, Kristelle, Ingram, Davis, May, Caitlin D, Kivlin, Christine M, Watson, Kelsey, Al Sannaa, Ghadah A, Wang, Wei-Lien, Ravi, Vinod, Pollock, Raphael E, Lev, Dina, Cormier, Janice N, Hunt, Kelly K, Feig, Barry W, Lazar, Alexander J, Torres, Keila E

“…Vascular leiomyosarcomas are a rare subtype of leiomyosarcomas that most commonly affect the inferior vena cava and account for 5% of all leiomyosarcomas…”
Get more information

Activated MET Is a Molecular Prognosticator and Potential Therapeutic Target for Malignant Peripheral Nerve Sheath Tumors by TORRES, Keila E, ZHU, Quan-Sheng, BELOUSOV, Roman, SUIZHAU WANG, LAHAT, Guy, JUN LIU, HERNANDEZ, Belinda, LAZAR, Alexander J, LEV, Dina, BILL, Katelynn, LOPEZ, Gonzalo, GHADIMI, Markus P, XIANBIAO XIE, YOUNG, Eric D, JUEHUI LIU, NGUYEN, Theresa, BOLSHAKOV, Svetlana

“…MET signaling has been suggested a potential role in malignant peripheral nerve sheath tumors (MPNST). Here, MET function and blockade were preclinically…”
Get full text

Cell-surface vimentin-positive macrophage-like circulating tumor cells as a novel biomarker of metastatic gastrointestinal stromal tumors by Li, Heming, Meng, Qing H., Noh, Hyangsoon, Somaiah, Neeta, Torres, Keila E., Xia, Xueqing, Batth, Izhar S., Joseph, Cissimol P., Liu, Mengyuan, Wang, Ruoyu, Li, Shulin

“…The clinical utility of circulating tumor cells (CTCs) has been investigated in numerous publications, but CTCs that express very typical immune cell markers…”
Get full text

Combined Modality Management of Retroperitoneal Sarcomas: A Single-Institution Series of 121 Patients by Bishop, Andrew J., MD, Zagars, Gunar K., MD, Torres, Keila E., MD, PhD, Hunt, Kelly K., MD, Cormier, Janice N., MD, MPH, Feig, Barry W., MD, Guadagnolo, B. Ashleigh, MD, MPH

“…Purpose The purpose of this study was to investigate local control, survival outcomes, and complication rates of patients treated with aggressive surgery and…”
Get full text

Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma by Roland, Christina L., May, Caitlin D., Watson, Kelsey L., Al Sannaa, Ghadah A., Dineen, Sean P., Feig, Rachel, Landers, Sharon, Ingram, Davis R., Wang, Wei-Lien, Guadagnolo, B. Ashleigh, Feig, Barry, Hunt, Kelly K., Cormier, Janice N., Lazar, Alexander J., Torres, Keila E.

“…Background Undifferentiated pleomorphic sarcomas (UPS) present a diagnostic and therapeutic challenge. Identification of prognostic molecular markers is…”
Get full text

Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients by Brudvik, Kristoffer W., Patel, Sameer H., Roland, Christina L., Conrad, Claudius, Torres, Keila E., Hunt, Kelly K., Cormier, Janice N., Feig, Barry W., Aloia, Thomas A., Vauthey, Jean-Nicolas

“…Background We investigated outcomes by primary tumor type in patients who underwent resection of liver metastases from gastrointestinal stromal tumors (GIST),…”
Get full text

Analysis of Prognostic Factors Impacting Oncologic Outcomes After Neoadjuvant Tyrosine Kinase Inhibitor Therapy for Gastrointestinal Stromal Tumors by Bednarski, Brian K., Araujo, Dejka M., Yi, Min, Torres, Keila E., Lazar, Alexander, Trent, Jonathan C., Cormier, Janice N., Pisters, Peter W. T., Lev, Dina Chelouche, Pollock, Raphael E., Feig, Barry W., Hunt, Kelly K.

“…Background Management of gastrointestinal stromal tumors (GISTs) has been transformed with tyrosine kinase inhibitors (TKIs). While data on optimal duration of…”
Get full text

Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biology by Rasmussen, Samuel V., Jin, Jia xiang, Bickford, Lissett R., Woods, Andrew D., Sahm, Felix, Crawford, Kenneth A., Nagamori, Kiyo, Goto, Hiroaki, Torres, Keila E., Sidoni, Angelo, Rudzinski, Erin R., Thway, Khin, Jones, Robin L., Ciulli, Alessio, Wright, Hollis, Lathara, Melvin, Srinivasa, Ganapati, Kannan, Kavya, Huang, Paul H., Grünewald, Thomas G. P., Berlow, Noah E., Keller, Charles

“…Background Metastatic epithelioid sarcoma (EPS) remains a largely unmet clinical need in children, adolescents and young adults despite the advent of EZH2…”
Get full text